diagnostics will continue to remain the mainstay within healthcare: dr lal path labs | cnbc tv18
Published 6 months ago • 4.4K plays • Length 10:12Download video MP4
Download video MP3
Similar videos
-
27:16
know all about dr lal path labs, srl diagnostics' ipo & apollo hospitals | the medicine box
-
22:46
in focus: dr lal path labs, srl diagnostics' ipo & apollo hospitals | the medicine box | cnbc-tv18
-
16:07
dr lal path labs' om manchanda exclusive on the changing landscape of diagnostics | the medicine box
-
1:20
diagnostic companies: antique initiates sell on dr lal pathlabs & metropolis | trading hour
-
28:36
live | on the record: dr lal pathlabs | 75 years of legacy | exclusive | n18l | cnbc tv18
-
13:03
why you can't get a diagnosis
-
13:48
mr saurabh mukherjea on 'how to think like and then become a monopolist?'
-
14:03
dr lal pathlabs ceo explains business model
-
8:33
dr lal path labs' om manchanda speaks on q4 performance & fy24 margin outlook | cnbc-tv18
-
11:55
dr lal path lab vs metropolis vs thyrocare | top stock in diagnostic sector in india?
-
9:12
aspiration is to grow in double digit with margin at 26% in fy25: dr lal pathlabs | cnbc tv18
-
1:04
ubs ups target price for dr lal path labs, says concerns about low patient vol growth likely to fade
-
2:30
dr lal path labs q2 pat declines 25% to ₹72.4 crore, metropolis healthcare's profit falls in q2
-
9:16
price increase is one of the reasons for the margin expansion: dr lal pathlabs | cnbc tv18
-
3:31
insight edge: dr lal pathlabs buzzing in trade after reports weak set of q4 numbers | cnbc-tv18
-
1:24
goldman sachs downgrades dr lal pathlabs & metropolis healthcare to sell, slashes target price
-
7:21
dr lal path labs' om manchanda speaks on rising competition in diagnostics | bazaar open exchange
-
2:07
kotak instl eq upgrades dr lal pathlabs to add from sell, metropolis healthcare's fair value raised
-
7:40
dr lal pathlabs' bharath uppiliappan speaks on the firm's q2fy23 results | bazaar morning call
-
1:05:33
august 5, 2024 cardiology vmr with drs. k. nguyen, v. pankayatselvan, r. ohman - failure to thrive
-
16:02
dr lal pathlabs: earnings and future expansion plans | #battleforkarnataka | cnbc tv18